Optimizing DC vaccination by combination with cytokine-expressing oncolytic adenoviruses

被引：0
|
作者：
Yun, Chae-Ok [1 ]
机构：
[1] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2014年 / 16卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
S2-4
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [41] Combined Mesothelin-Redirected Chimeric Antigen Receptor T Cells with Cytokine-Armed Oncolytic Adenoviruses for the Treatment of Pancreatic Cancer
    Watanabe, Keisuke
    Luo, Yanping
    Da, Tong
    Guedan, Sonia
    Ruella, Marco
    Scholler, John
    Keith, Brian
    Young, Regina M.
    Engels, Boris
    Sorsa, Suvi
    Siurala, Mikko
    Havunen, Riikka
    Tahtinen, Siri
    Carrascon, Victor
    Hemminki, Akseli
    June, Carl H.
    MOLECULAR THERAPY, 2018, 26 (05) : 7 - 8
  • [42] Optimizing oncolytic vaccinia virus and anti-CTLA4 combination therapy to treat cancer
    Rojas, Juan
    Sampath, Padmavathi
    Hou, Weizhou
    Stephen, Thorne
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [43] Individual cytokine-expressing CD4 T cell subsets, their functional affinity and organ distribution in the course of chronic, relapsing EAE in SJL mice
    Karulin, AY
    Hesse, MD
    Targoni, OS
    Lehmann, PV
    FASEB JOURNAL, 1999, 13 (05): : A1124 - A1124
  • [44] OMICS ANALYSIS OF THE ANTI-GLIOMA EFFECT BY COMBINATION THERAPY OF VASCULOSTATIN EXPRESSING ONCOLYTIC VIRUS AND CILENGITIDE
    Fujii, Kentaro
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Onishi, Manabu
    Ishida, Joji
    Shimazu, Yosuke
    Kaur, Balveen
    Chiocca, E. Antonio
    Date, Isao
    NEURO-ONCOLOGY, 2013, 15 : 140 - 140
  • [45] Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease
    Pott, GB
    Palmer, BE
    Sullivan, AK
    Silviera, L
    Maier, LA
    Newman, LS
    Kotzin, BL
    Fontenot, AP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) : 1036 - 1042
  • [46] Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids
    Geissler, M
    Gesien, A
    Wands, JR
    JOURNAL OF IMMUNOLOGY, 1997, 159 (10): : 5107 - 5113
  • [47] Optimizing the tolerability of intravenous oncolytic viral immunotherapy administration: A sub-analysis of tolerability and cytokine data from the EVOLVE study of enadenotucirev (EnAd), an oncolytic adenovirus
    McElwaine-Johnn, H.
    Pover, G.
    Alvis, S.
    Brown, R.
    Fisher, K.
    Morris, C.
    Champion, B.
    Beadle, J.
    ANNALS OF ONCOLOGY, 2017, 28 : 14 - 14
  • [48] Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors
    Fujii, S
    Hamada, H
    Fujimoto, K
    Shimomura, T
    Kawakita, M
    BLOOD, 1999, 93 (12) : 4328 - 4335
  • [49] Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
    T Du
    G Shi
    Y M Li
    J F Zhang
    H W Tian
    Y Q Wei
    H Deng
    D C Yu
    Cancer Gene Therapy, 2014, 21 : 340 - 348
  • [50] Oncolytic adenoviruses expressing metabolic targets can improve viro-immunotherapy with bispecific T cell engagers through reducing acidosis in an in vitro model
    Dyer, Arthur
    Frost, Sally
    Caviezel, Flurin
    Seymour, Len
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
12345